Top Markets
#1 TENDIES TENDIES +42.31%
#2 Cash Cat Cash Cat +24.22%
#3 Asteroid Shiba Asteroid Shiba +16.17%
#4 OSK OSK +15.36%
#5 龙虾 (Lobster) 龙虾 (Lobster) +10.93%
#6 Bluwhale Bluwhale +10.55%
#7 MarsCoin MarsCoin +8.17%
#8 Threshold Network Threshold Network +7.55%
#9 Pyth Network Pyth Network +7.25%
#10 Tornado Cash Tornado Cash +6.90%
Coin of the day
TENDIES TENDIES
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
Classement en actions #16737
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Prix de l'action
$2.47
Capitalisation boursière
$269.48M
Changement (1 jour)
-1.43%
Changement (1 an)
-56.93%
Pays
CN
Échange VISEN Pharmaceuticals (2561)

Catégorie

Healthcare
Le prix 2561 avec la capitalisation boursière de B
VISEN Pharmaceuticals VISEN Pharmaceuticals
2561
$2.47
Capitalisation boursière de VISEN Pharmaceuticals(2561)
Capitalisation boursière: $269.48M
En September 2026, VISEN Pharmaceuticals a une capitalisation boursière de $269.48M. Cela fait de VISEN Pharmaceuticals la 16737th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de VISEN Pharmaceuticals du 2025 au 2026
2561 par rapport au top 5 des plus populaires stocks
Prix pour 2561 L’actif B La capitalisation boursière de B Résultats
VISEN Pharmaceuticals VISEN Pharmaceuticals
$48,237.65 $269.48M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.260T +1,951,628.50%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$43,825.52 $269.48M
Apple Inc. Apple Inc.
AAPL
$4.779T +1,773,110.67%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$36,838.88 $269.48M
Alphabet Inc. Alphabet Inc.
GOOG
$4.017T +1,490,426.57%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$34,111.04 $269.48M
Microsoft Corporation Microsoft Corporation
MSFT
$3.719T +1,380,056.11%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$25,076.63 $269.48M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.734T +1,014,517.80%